functions via two classical nuclear receptors (nERs; ERα and ERβ) and/ or one membrane receptor (mER, also known as GPR30 or GPER-1).
Numerous studies have indicated the critical roles of these receptors in the regulation of hippocampal synaptic plasticity, spatial learning, and memory performance. [5] [6] [7] [8] [9] [10] For example, an ERβ agonist facilitated actin polymerization in adult rat hippocampal slices. 11 An ERα antagonist impaired the expression of synapsins, a family of proteins that have long been implicated in the regulation of neurotransmitter release at synapses and, thus, affect the strength of synaptic transmission. 12 An ERα selective antagonist MPP (1, shown to block the protective effect of E2 against neuronal death in cultured rat hippocampal neurons 13 and modulate the reorganization of the actin cytoskeleton in rat hippocampal slices. 14 protein expression and spatial recognition acquisition. 7, 8, 10 However, the related mechanisms and whether there are any differences between the contributions of nERs and mER to E2 regulation of hippocampal synaptic structural plasticity are not clarified.
Two decades ago, McEwen and colleagues provided primary ev-
idence showing that E2 could increase hippocampal CA1 dendritic spine and synapse density. 17, 18 Dendritic spines are mushroomshaped protrusions of the postsynaptic membrane; their number and shape are regulated by actin cytoskeleton polymerization, which is determined by the shift between soluble G-actin monomers and insoluble F-actin filaments. 19, 20 Cofilin has been shown to be responsible for the depolymerization of F-actin, and profilin-1 has been shown to be responsible for the polymerization of G-actin. 21, 22 Interestingly, recent studies have shown that in the hippocampus, actin cytoskeleton polymerization is controlled by mammalian target of rapamycin complex 2 (mTORC2). Using mTORC2-deficient mice in which rictor, the regulatory component of mTORC2 was conditionally deleted, and mTORC2 has been demonstrated to affect neuronal morphology, synaptic function, and long-term memory formation through regulation of actin cytoskeleton polymerization. 23, 24 Additional evidence has shown that in the brain of aged mice and flies, loss of mTORC2-mediated actin polymerization contributed to age-associated memory loss, which could be reversed by mTORC2 activation with A-443654, the specific mTORC2 activator. 25 Sun et al reported that in the hippocampus of both wild-type and Angelman syndrome mice, LTP and actin polymerization were significantly increased by A-443654 treatment. 26 Furthermore, several pieces of evidence have shown that mTORC2 could be stimulated by E2 administration in breast cancer 27 and that mTORC2 activation could be modulated by E2 in female cardiomyocytes. 28 Meanwhile, our previous studies revealed that in the hippocampus of mice, mTORC2 signaling and actin polymerization could be regulated by letrozole, the E2 synthase inhibitor, or E2 administration. 29 However, whether mTORC2 activation is involved in estrogen receptor regulation of hippocampal synaptic structural plasticity is not clearly elucidated.
To address the above issues, in this study, we first examined the expression of steroid receptor coactivator-1 (SRC-1), mTORC2 signaling molecules, actin polymerization regulatory proteins, and some key synaptic proteins after injection of G15 or a combination of MPP and PHTPP alone or combined with A-443654 in vivo. Then, we examined the changes in CA1 dendritic spine and synapse density under MPP/ PHTPP, G15, and A-443654 treatment. In our preliminary time-dependent (1-day, 3-days, or 7-days) tests, we found that G15, MPP, and PHTPP treatment induced a significant decrease in rictor, p-AKT(Ser473)/AKT, p-cofilin(Ser3), and profilin-1 expression, mostly seen after 3 days (P < 0.05) and especially after 7 days (P < 0.01). Furthermore, we observed that G15 treatment induced a learning and memory impairment at day 4 (Y. Zhang, M. Liu, Y. Zhao, L. He, J. Zhao, F. Xing and J. Zhang, unpublished data). Similar behavior impairments were also detected after MPP and PHTPP treatment. 30 Thus, a 7-days treatment duration was used in this study. Mice were anaesthetized with 100 mg/kg sodium pentobarbital before injection; the drugs were given intraperitoneally every morning (from 09:00 to 11:00) for 1 week.
| MATERIALS AND METHODS

| Animals and drug administration
| Tissue preparation and immunohistochemistry
Tissue preparation and immunohistochemistry were performed as described previously. 31 were dehydrated, cleared with xylene, and mounted.
Then, the slides were imaged using an Olympus microscope (BX60, Olympus, Tokyo, Japan), and the images were captured using a digital camera (DP70, Leica Microsystems, Germany). The average optical density was analyzed using Image-Pro Plus software 6.0 (Media Cybernetics, Rockville, USA) according to the user manual, and the mean value of the entire hippocampus (including CAs and dentate gyrus) was used to represent the regional expression level for each group. To prevent the detection of false changes between groups due to possible differences in the localization of similar anatomical areas along the anterior to posterior axis, only stained sections between Bregma −1.70 and Bregma −2.18 were used for data analysis, ensuring the highest possible consistency between groups. The mean optical density from 3 to 5 sections from each hippocampus was used to represent the regional expression level for each animal.
| Western blot analysis
To examine the expression of the hippocampal synaptic proteins, mTORC2 signaling proteins, and actin remodeling proteins before and after drug treatments, mice were sacrificed, and the hippocampi were dissected and lysed with RIPA buffer (P0013B, Beyotime Biotech, Beijing, China) containing protease inhibitor cofilin ratios, the phospho-antibodies were first used in the protocol described above. Then, the membranes were washed with a specific stripping buffer (P0023A, Beyotime Biotech), blocked with 5% freshly prepared milk-TBST, and incubated with the primary antibodies against AKT or cofilin, followed by the next steps described above. Finally, the blots were developed with a chemiluminescent 
| Golgi-Cox staining and dendritic spine measurement
To assess the effects of the drug treatments on the spine density in hippocampal neurons, Golgi staining was carried out using the FD Rapid Golgi Stain Kit (PK401, FD NeuroTechnologies, Columbia, USA)
according to the manufacturer's instructions. In short, mice were anesthetized, and the whole brain was dissected, rinsed in distilled water, and then immersed in the Golgi-Cox solution (Solution A:B = 1:1), which was changed to fresh solution the next day. The brains were kept in darkness for 2 weeks at room temperature, followed by immersion in Solution C for 3 days at 4°C in darkness. The brains were then cut into 200-μm-thick slices with a vibratome (Microslicer DTK-600, Dosaka EM, Tokyo, Japan), and the slices were mounted on gelatin-coated slides and air-dried in a dark place. The slices were then stained with a mixture of Solution D, Solution E, and distilled water (1:1:2) for 10 minutes. Then, the slides were dehydrated in 50%, 75%, 95%, and 100% alcohol. Finally, the sections were cleaned, mounted, and photographed with an Olympus microscope (100× oil immersion lens). Then, the number of dendritic spines along the secondary branching of the dendrites of CA1 pyramidal neurons was measured with Image-Pro Plus software (Media Cybernetics), and the number of dendritic spines per 10 μm was counted and used for further analysis.
| Transmission electron microscopy
Transmission electron microscopy was used to evaluate the changes in synapse density in the CA1 region of the hippocampus after drug treatment. Briefly, the hippocampi were dissected, rapidly transferred into 2.5% glutaraldehyde, cut into slices containing the upper and the middle of the CA1 stratum radiatum, and fixed in glutaraldehyde for 3 days. After the sections were washed with 
| Statistical analysis
All statistics were analyzed using SPSS software, and the data were shown as the mean ± SE. For multiple-group comparisons, a one-way ANOVA and post hoc test were used. To analyze the contribution of nERs or mER to the hippocampal synaptic plasticity-related parameters, a ratio (%) describing the decrease in expression of specific proteins after MPP/PHTPP or G15 treatment was compared using an independent-sample t-test. In both conditions, P < 0.05 was considered to be statistically significant.
| RESULTS
We first used immunohistochemistry to verify the subcellular localization of nERs (ERα and ERβ) and mER in the hippocampus of adult mice. As shown in Figure 1A -C, the nER-immunopositive material was predominantly detected in the cell nuclei, while mER-immunopositive staining was predominantly detected in the plasma membrane.
| The MPP/PHTPP-and G15-induced decrease in SRC-1 was not reversed by A-443654
SRC-1 has been shown to enhance the transcriptional activity of nuclear steroid receptors. and G15 groups (P > 0.05) as shown in Figure 1D -G. Therefore, the ER antagonists induced a decrease in SRC-1 expression that was not restored by A-443654 treatment.
F I G U R E 2
The MPP/PHTPP-and G15-induced decreases in p-AKT, AKT, and rictor expression were differently affected by mTORC2 activation with A-443654 in the adult female hippocampus. A,B, The MPP/PHTPP-and G15-induced dramatic decrease in p-AKT was significantly rescued by A-443654, while the levels of AKT were not affected by any of the treatments. Therefore, the p-AKT/AKT ratio showed a significant decrease after MPP/PHTPP and G15 treatment, and this decrease was reversed by A-443654 treatment. **P < 0.01 when compared to other groups (one-way ANOVA and post hoc test). C,D, Neither the MPP/PHTPP-nor G15-induced decrease in rictor expression was reversed by A-443654. **P < 0.01 when compared to the control (DMSO; one-way ANOVA and post hoc test)
| The MPP/PHTPP-and G15-induced decrease in p-AKTSer473 but not rictor was reversed by A-443654
Rictor is the regulatory component of mTORC2, and p-AKTSer473
(p-AKT) is the direct target of the mTORC2 cascade, which is activated by A-443654. As shown in Figure 2A 
| The MPP/PHTPP-and G15-induced decreases in actin cytoskeleton remodeling proteins were reversed by A-443654
Cofilin is an actin cytoskeleton polymerization disruptor, and its phosphorylation on serine 3 (p-cofilin) is known to block this activity. As shown in Figure 3A ,B, the one-way ANOVA and post hoc test on the expression of cofilin showed that there were no differences among and among the control, G15, and G15/A-443654 treatment groups (F (2,15) = 11.944, P = 0.001). MPP/PHTPP and G15 treatment induced a significant decrease in p-cofilin when compared to the control (P < 0.01); this decrease was significantly reversed by A-443654 (P < 0.01 when compared to p-cofilin expression in the respective MPP/PHTPP and G15 groups) and reached the control level (P > 0.05 when compared to the expression in the control). Therefore, the ratio of p-cofilin/cofilin was significantly downregulated by MPP/ PHTPP and G15 treatment (P < 0.01 when compared to the ratio in the control), and this decrease was rescued after A-443654 treatment (P < 0.01 when the ratio was compared to that of the respective MPP/ PHTPP and G15 groups). Furthermore, there were no significant differences in the p-cofilin/cofilin ratio between the control and MPP/ PHTPP/A-443654 or between the G15 and G15/A-443654 groups (P > 0.05).
Immunohistochemistry was employed to examine the changes in the expression of profilin-1, the actin polymerization stabilizer, after treatment with the ER antagonists by themselves or in combination 
| Hippocampal synaptic proteins were differentially regulated by MPP/PHTPP, G15, and A-443654
Western blot analysis was used to examine the expression of several synaptic proteins including postsynaptic GluR1, PSD95, spinophilin, and presynaptic synaptophysin. There were significant differences in when GluR1 expression was compared to that in the MPP/PHTPP and G15 groups (P < 0.01). However, there were no differences in
GluR1 expression between the control and MPP/PHTPP/A-443654 groups (P > 0.05) or between the control and G15/A-443654 groups (P > 0.05). These results are shown in Figure 4A ,B.
For PSD95, there were significant differences among the con- 
| The MPP/PHTPP-and G15-induced decreases in spine density and synapse density were reversed by A-443654
Dendritic spine density and synapse density are important parameters for synaptic plasticity. We used Golgi-Cox staining to examine the CA1 spine density and transmission electronic microscopy to examine the CA1 synapse density. For the changes in the spine density, a one-way ANOVA and post hoc test revealed that there were significant differences among the control, MPP/PHTPP, and MPP/PHTPP/A-443654 treatment groups (F (2,42) = 111.601, P = 0.000) and among the control,
G15
, and G15/A-443654 treatment groups (F (2,42) = 16.422, P = 0.000).
F I G U R E 3
The MPP/PHTPP-and G15-induced decreases in the expression of actin cytoskeleton regulator proteins were reversed by mTORC2 activation with A-443654 in the adult female hippocampus. A,B, Western blot results showed that both the MPP/PHTPP-and G15-induced dramatic decrease in p-cofilin were significantly reversed by A-443654, but these treatments did not affect the expression of cofilin. Therefore, the p-cofilin/cofilin ratio showed a significant decrease after MPP/PHTPP and G15 treatment, and this decrease was reversed by A-443654 treatment. C,D, Immunohistochemistry results showed that the MPP/PHTPP-and G15-induced dramatic decrease in profilin-1 expression was significantly reversed by A-443654. **P < 0.01 when compared to other groups (one-way ANOVA and post hoc test). Bar=200 μm There were also significant differences in synapse density among the control, MPP/PHTPP, and MPP/PHTPP/A-443654 treatment groups (F (2,27) = 33.515, P = 0.000) and among the control, G15, and G15/ A-443654 treatment groups (F (2,27) = 11.710, P = 0.000). Specifically, CA1 spine density and synapse density were significantly decreased by MPP/PHTPP and G15 treatment when compared to those in the control group (P < 0.01). A-443654 administration significantly reversed these decreases when the CA1 spine and synapse densities were compared to those of the MPP/PHTPP and G15 treatment groups (P < 0.01), and the spine and synapse densities reached the control level (P > 0.05 when compared to those in the control group), as shown in Figure 5A -D.
| MPP/PHTPP and G15 induced similar changes in synaptic protein expression and actin polymerization
Finally, to evaluate the contributions of nERs and mER in E2 actions on hippocampal synaptic plasticity-related changes in synaptic
The MPP/PHTPP-and G15-induced changes in synaptic protein expression were differently affected by mTORC2 activation with A-443654 in the adult female hippocampus. A-F, Western blot results showed that the MPP/PHTPP-and G15-induced dramatic decreases in GluR1 (A,B), PSD95 (C,D), and spinophilin (E,F) were significantly reversed by A-443654. G,H, MPP/PHTPP or G15 treatment and mTORC2 activation did not affect the expression of synaptophysin. Spino: spinophilin. SYN: synaptophysin. **P < 0.01 when compared to other groups (one-way ANOVA and post hoc test)
The effects of MPP/PHTPP, G15, and A-443654 on the spine and synapse density as well as the contributions of nERs and mER to changes in hippocampal synaptic plasticity-related protein expression and morphology. A,B, Golgi-Cox staining results showed that the MPP/PHTPP-and G15-induced dramatic decreases in the CA1 dendritic spines density were significantly reversed by A-443654 treatment. Bar = 10 μm. C,D, Transmission electronic microscopy results showed that the MPP/PHTPP-and G15-induced dramatic decreases in CA1 synapse density were significantly reversed by A-443654. The white arrows in C and D indicate detected synapses. Bar = 1 μm. **P < 0.01 when compared to other groups (one-way ANOVA and post hoc test). E, The contributions of nERs and mER to the regulation of hippocampal synaptic plasticity-related protein expression and morphology. The results showed that nERs and mER contributed similarly to most of the examined parameters (P > 0.05, independent-sample t-test). However, G15 induced a greater decrease in p-cofilin, GluR1, and spinophilin expression than MPP. *P < 0.05 (independent-sample t-test). Spino: spinophilin. SYN: synaptophysin proteins and actin polymerization, we compared the decreased level of the above-mentioned parameters, including SRC-1, p-AKT, rictor, and actin remodeling proteins (p-cofilin and profilin-1), postsynaptic proteins (GluR1, PSD95, and spinophilin), as well as the density of dendritic spines and synapses, between the MPP/ PHTPP and G15 treatment groups. As shown in Figure 5E , there were no significant differences for most of the examined parameters (P > 0.05); the expression levels of only three of the proteins (p-cofilin, GluR1, and spinophilin) were significantly lower after G15 treatment than after MPP/PHTPP treatment (P < 0.05). Thus, nERs and mER might play similar roles and be similarly effective in the regulation of synaptic protein expression and actin polymerization dynamics.
| DISCUSSION
E2 is well established to regulate hippocampal structure and function including actin cytoskeleton polymerization, 29 expression of synaptic proteins, 36 induction of LTP 37 , and behavior. cell nuclei [39] [40] [41] and that mER was present in the plasma membrane. 42 As high levels of SRC-1 have been detected in the hippocampus [43] [44] [45] [46] [47] and have been shown to be regulated by postnatal development and aging 46, 48, 49 and mediate the effects of E2 on hippocampal PSD95 50 as well as actin depolymerization, 29 we then examined the changes in SRC-1 expression after nER and mER antagonist treatment and mTORC2 activation. We observed that SRC-1 expression was suppressed by nER and mER antagonists, strongly indicating its central role in mediating the actions of both nERs and mER. We also found that the levels of hippocampal SRC-1 were not regulated by mTORC2 activation with A-443654, indicating that SRC-1 might not be downstream
The actin cytoskeleton is the structural element of dendritic spines, 20 and its polymerization within the dendritic spine has been shown to play pivotal roles in hippocampal synaptic plasticity and hippocampus-based learning and memory. 51 We therefore examined the expression of some actin cytoskeleton remodeling proteins (rictor, p-AKT/AKT, p-cofilin/cofilin, and profilin-1) after treatment with nER or mER antagonists. In our preliminary tests, we found that G15, MPP, and PHTPP treatment induced significant changes in mTORC2 signals and actin polymerization-related proteins, mostly seen after 3 days and especially after 7 days of treatment, and the behavioral changes induced by these antagonists were detected after 4 days of treatment. , and postsynaptic protein expression (GluR1, PSD95, and spinophilin) and finally affected the dendritic spine and synapse density. The impaired actin polymerization and decreased postsynaptic protein expression, spine density, and synapse density were significantly reversed by activation of mTORC2 with A-443654. Spino: spinophilin actin polymerization, 26 and in the brain of fruit flies and aged mice, A-443654 treatment reversed the loss of mTORC2-mediated actin polymerization. 25 Thus, our current studies provided novel insights into the understanding of the mechanisms of ER regulation of actin polymerization.
Hippocampal synaptic protein levels, dendritic spine density, and synapse density are important components of synaptic plasticity. Our current results showed that levels of postsynaptic GluR1 and PSD95
as well as the dendritic spine marker spinophilin were significantly downregulated by MPP/PHTPP and G15 treatment. Additionally, the spine density and synapse density were also significantly downregulated by MPP/PHTPP and G15 treatment. These results were in agreement with previous findings showing that nER activation improved the levels of hippocampal synaptic proteins (GluR1 and PSD95) and synapse loss induced by ovariectomy 6, 53 and that mER activation increased the expression of PSD95 in the hippocampus. 54 These observations were also in agreement with the studies shown that the levels of PSD95 and spinophilin and the spine density and synapse density were upregulated by E2 treatment. 17, 18, 55 . Meanwhile, we
found that the expression of the presynaptic protein synaptophysin was not regulated by MPP/PHTPP or G15 treatment. To some extent, this result was in general agreement with a previous study showing that hippocampal synaptophysin was not affected by castration or ovariectomy. 56 Furthermore, we noticed that the MPP/PHTPP-and G15-induced decreases in the above parameters were significantly rescued by mTORC2 activation with A-443654. To the best of our knowledge, this is the first report on the effects of mTORC2 activation on the expression of these synaptic proteins and changes in spine and synapse density.
A few studies have compared the contributions and differences between nER and mER in the mediation of estrogenic action. Romano et al proposed that nERs and mER might influence parallel pathways to achieve similar effects. 57 Our recent studies revealed that treatment with MPP, PHTPP, or an MPP/PHTPP combination induced similar changes in selected synaptic protein expression as well as the F-actin/ G-actin ratio. 30 In the present study, we further examined the contributions of MPP/PHTPP and G15 to the changes in the expression of these synaptic proteins and actin polymerization. We found that most of the parameters were not significantly different. Thus, these data strongly indicated that nERs and mER might contribute similarly to the regulation of hippocampal synaptic plasticity, similar to that proposed by Romano et al 57 However, the underlying mechanisms are far from clear.
| CONCLUSIONS
Previously, we found that the upregulation of mTORC2 signals, actin polymerization, and expression of synaptic proteins by nER agonists was blocked by SRC-1 RNA interference. 30 We also found that the mER agonist G1-induced increase in mTORC2 signals was proteins, actin polymerization remodeling proteins, and postsynaptic proteins as well as in the spine and synapse density. Moreover, the ER antagonist-induced decreases in actin polymerization, postsynaptic proteins, spine density, and synapse density were rescued by activation of mTORC2 with A-443654. Thus, we summarized these results in Figure 6 . Additionally, we demonstrated that both nERs and mER showed similar effects on hippocampal synaptic plasticity-related protein expression and morphology. These results provided a novel insight into the mechanisms underlying E2 regulation of actin cytoskeleton polymerization-based structural plasticity as well as hippocampus-based learning and memory.
Furthermore, because of the role of the hippocampus in neurodegenerative diseases such as Alzheimer's disease (AD) and the controversial effects of E2 replacement against AD, 58, 59 these preliminary results may also provide a novel, alternative drug target for the prevention and treatment of AD as proposed in previous studies. 23, 25, 30, 60 
